These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 15477098)

  • 1. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment.
    Inayathullah M; Satheeshkumar KS; Malkovskiy AV; Carre AL; Sivanesan S; Hardesty JO; Rajadas J
    PLoS One; 2013; 8(12):e85160. PubMed ID: 24386462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural preferences of Aβ fragments in different micellar environments.
    Sambasivam D; Sivanesan S; Ashok BS; Rajadas J
    Neuropeptides; 2011 Dec; 45(6):369-76. PubMed ID: 22019176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
    J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species.
    Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D
    J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study.
    Di Natale G; Impellizzeri G; Pappalardo G
    Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
    Walsh P; Yau J; Simonetti K; Sharpe S
    Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct morphological and electrophysiological properties of an elk prion peptide.
    Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
    Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles.
    Rangachari V; Reed DK; Moore BD; Rosenberry TL
    Biochemistry; 2006 Jul; 45(28):8639-48. PubMed ID: 16834338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
    Ohnishi S; Koide A; Koide S
    J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein peptides induce alpha-helix to beta-sheet conformational transitions.
    Nguyen J; Baldwin MA; Cohen FE; Prusiner SB
    Biochemistry; 1995 Apr; 34(13):4186-92. PubMed ID: 7703230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
    Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
    Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.